Compare BHVN & INTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BHVN | INTA |
|---|---|---|
| Founded | 2013 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.8B |
| IPO Year | 2022 | 2021 |
| Metric | BHVN | INTA |
|---|---|---|
| Price | $15.44 | $29.02 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 7 |
| Target Price | $29.08 | ★ $41.43 |
| AVG Volume (30 Days) | ★ 3.6M | 810.3K |
| Earning Date | 05-11-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 26.08 | ★ 48.89 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $504,120,000.00 |
| Revenue This Year | N/A | $15.91 |
| Revenue Next Year | N/A | $13.78 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 17.09 |
| 52 Week Low | $7.48 | $19.01 |
| 52 Week High | $18.57 | $47.93 |
| Indicator | BHVN | INTA |
|---|---|---|
| Relative Strength Index (RSI) | 57.56 | 65.57 |
| Support Level | $14.44 | $20.15 |
| Resistance Level | $17.01 | $29.47 |
| Average True Range (ATR) | 1.01 | 1.34 |
| MACD | -0.28 | 0.23 |
| Stochastic Oscillator | 49.72 | 82.30 |
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.
Intapp Inc is a provider of industry-specific, cloud-based software solutions for the professional and financial services industry. It empowers private capital, legal, accounting, and consulting firms with the technology needed to meet rapidly changing client, investor, and regulatory requirements. Geographically, it derives a majority of its revenue from the United States and also has a presence in the United Kingdom and the Rest of the world.